Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
04 Dec 2023
Approval to Initiate Phase2 Pancreatic Cancer Trial in Korea
21 Nov 2023
Appendix 4D and Financial Report Half Year ended 30 Sep 23
31 Oct 2023
Quarterly Activities/Appendix 4C Cash Flow Report
30 Oct 2023
Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
19 Oct 2023
Amplia Receives R&D Tax Rebate Totalling $ 2.4 Million
09 Oct 2023
AACR Ovarian Cancer Conference Presentation
29 Sep 2023
AACR Pancreatic Cancer Conference Presentation
25 Sep 2023
New Chief Financial Officer Mr Tim Luscombe
04 Sep 2023
Notification of cessation of securities - ATX
01 Sep 2023
Notification of cessation of securities - ATX
1
2
3
4
Next
